Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wakai, T.
Right arrow Articles by Hatakeyama, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wakai, T.
Right arrow Articles by Hatakeyama, K.
Related Collections
Right arrow Prognostic factors
Annals of Surgical Oncology 10:447-454 (2003)
© 2003 Society of Surgical Oncology


ORIGINAL ARTICLES

Depth of Subserosal Invasion Predicts Long-Term Survival After Resection in Patients With T2 Gallbladder Carcinoma

Toshifumi Wakai, MD, PhD, Yoshio Shirai, MD, PhD, Naoyuki Yokoyama, MD, PhD, Yoichi Ajioka, MD, PhD, Hidenobu Watanabe, MD, PhD and Katsuyoshi Hatakeyama, MD, PhD, FACS

From the Divisions of Digestive and General Surgery (TW, YS, NY, KH) and Molecular and Diagnostic Pathology (YA, HW), Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Correspondence: Address correspondence and reprint requests to: Yoshio Shirai, MD, PhD, Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Niigata City, 951-8510 Japan; Fax: 81-25-227-0779; E-mail: shiray{at}med.niigata-u.ac.jp

Background: This study aimed to identify a subgroup of patients with inapparent T2 gallbladder carcinoma who may be best suited for radical second resection.

Methods: A retrospective analysis was conducted of 126 patients with pathologic stage T2 (pT2) gallbladder carcinoma (51 with clinically evident tumor and 75 with inapparent tumor). Depth of subserosal invasion was measured histologically in each gallbladder specimen. The median follow-up period was 113 months.

Results: In all 126 patients, depth of subserosal invasion was the strongest independent prognostic factor by univariate (P < .0001) and multivariate (relative risk, 9.27; P < .0001) analyses. Among the 75 patients with inapparent tumor, the outcome after resection was significantly better in patients who had undergone radical second resection than in patients who had undergone cholecystectomy alone (P = .0006). When depth of subserosal invasion was divided into <=2 vs. >2 mm, the effectiveness of radical second resection remained only in patients with subserosal invasion >2 mm (P = .0004).

Conclusions: Depth of subserosal invasion best predicts postresectional long-term survival of pT2 gallbladder carcinoma patients. Among patients with inapparent pT2 tumors, those with subserosal invasion >2 mm are good candidates for radical second resection.

Key Words: Gallbladder neoplasms • Depth of invasion • Surgery • Lymph node dissection • Multivariate analysis • Prognosis




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
H. Yokomizo, T. Yamane, T. Hirata, M. Hifumi, T. Kawaguchi, and S. Fukuda
Surgical Treatment of pT2 Gallbladder Carcinoma: A Reevaluation of the Therapeutic Effect of Hepatectomy and Extrahepatic Bile Duct Resection Based on the Long-term Outcome
Ann. Surg. Oncol., April 1, 2007; 14(4): 1366 - 1373.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
J. M. Foster, H. Hoshi, J. F. Gibbs, R. Iyer, M. Javle, Q. Chu, and B. Kuvshinoff
Gallbladder Cancer: Defining the Indications for Primary Radical Resection and Radical Re-resection
Ann. Surg. Oncol., February 1, 2007; 14(2): 833 - 840.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
Y. Fong
Treatment of T2 Gallbladder Cancer
Ann. Surg. Oncol., June 1, 2003; 10(5): 490 - 490.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society of Surgical Oncology.